Page 3 - ப்ரிமியர் மருத்துவ ஆய்வகம் சேவைகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
One Year Since FDA Validation of South Carolina s First COVID-19 Testing Laboratory
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
One Year Since FDA Validation of South Carolina s First COVID-19 Testing Laboratory
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
GREENVILLE, S.C., March 4, 2021 /PRNewswire/ While COVID-19 vaccines are being administered in hopes of reducing the impact of the pandemic, novel variants of SARS-CoV-2, the virus that causes COVID-19, are spreading at accelerated rates. (1) Just as data analysis of the original strain of COVID-19 helped to determine patient care protocols and best safety practices, advanced surveillance of COVID-19 is now a critical component to understanding the new and emerging variants. That s why Premier Medical Laboratory Services (PMLS), an award-winning molecular diagnostics laboratory, is currently conducting a large-scale genomic surveillance of the SARS-CoV-2 virus. They have now expanded their next-generation sequencing (NGS) to 21,000 specimens per week, a capacity that surpasses most laboratories due to PMLS implementation of cutting-edge high throughput lab equipment which automates workflow.
Premier Medical Laboratory Services Launches Large-Scale Genomic Surveillance of COVID-19 Variants
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
DIABETESpredict®, a first of its kind predictive genetic test for type 2 diabetes, is now being administered to help improve patient outcomes during the COVID-19 pandemic. According to a recent study on the bidirectional relationship of type 2 diabetes and COVID-19, patients with type 2 diabetes are predisposed to adverse clinical outcomes from the COVID-19 virus. In addition, many COVID-19 patients are found to develop new onset diabetes after infection (1). DIABETESpredict® proactively determines a patient's type 2 diabetes genetic risk. It then provides physicians with individualized lifestyle and diet recommendations for the prevention and management of type 2 diabetes, helping to reduce the probability of severe infection by COVID-19 or post infection disease onset.